S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
Bear Market Funds to Watch This Year
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
Bear Market Funds to Watch This Year
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
Bear Market Funds to Watch This Year
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
Bear Market Funds to Watch This Year

Emergent BioSolutions (EBS) Earnings Date, Estimates & Call Transcripts

$1.86
-0.04 (-2.11%)
(As of 04/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Mar. 6)
-$0.77 Missed By -$0.44
Consensus EPS
(Mar. 6)
-$0.33
Skip Charts & View Estimated and Actual Earnings Data

EBS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EBS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Emergent BioSolutions Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($1.11)($1.11)($1.11) 
Q2 20241$0.78$0.78$0.78 
Q3 20241$0.83$0.83$0.83 
Q4 20241$1.59$1.59$1.59 
FY 20244$2.09$2.09$2.09 
Q1 20251$0.29$0.29$0.29 
Q2 20251$1.07$1.07$1.07 

EBS Earnings Date and Information

Emergent BioSolutions last released its quarterly earnings results on March 6th, 2024. The biopharmaceutical company reported ($0.77) EPS for the quarter, missing the consensus estimate of ($0.33) by $0.44. The firm earned $276.60 million during the quarter, compared to the consensus estimate of $247.63 million. Emergent BioSolutions has generated ($14.83) earnings per share over the last year (($14.83) diluted earnings per share). Earnings for Emergent BioSolutions are expected to grow in the coming year, from ($13.98) to ($0.25) per share. Emergent BioSolutions has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Emergent BioSolutions Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
3/6/2024Q4 2023($0.33)($0.77)($0.44)($0.59)$247.63 million$276.60 million      
12/11/2023Q3 2023($0.12)($1.44)($1.32)$2.20$255.34 million$270.50 million
8/8/2023Q2 2023($0.98)($1.06)($0.08)$3.03$216.17 million$337.90 million    
5/9/2023Q1 2023($1.67)($3.17)($1.50)($2.69)$142.85 million$165.10 million    
2/27/2023Q4 2022$0.31($0.31)($0.62)$1.14$298.23 million$330.70 million    
11/8/2022Q3 2022($0.06)($1.27)($1.21)($1.02)$268.17 million$240.00 million
8/1/2022Q2 2022$0.63($0.86)($1.49)($0.59)$268.77 million$242.70 million    
4/28/2022Q1 2022$0.24$0.18($0.06)$0.43$282.54 million$307.50 million    
2/24/2022Q4 2021$3.89$4.50+$0.61$5.50$676.90 million$723.40 million    
11/4/2021Q3 2021$2.35($0.36)($2.71)($0.11)$484.77 million$329.00 million    
7/29/2021Q2 2021$1.81$0.33($1.48)$0.57$415.73 million$397.50 million    
4/28/2021Q1 2021$0.97$1.53+$0.56$1.78$368.62 million$343.00 million  

Emergent BioSolutions Earnings - Frequently Asked Questions

When is Emergent BioSolutions's earnings date?

Emergent BioSolutions has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on EBS's earnings history.

Did Emergent BioSolutions beat their earnings estimates last quarter?

In the previous quarter, Emergent BioSolutions (NYSE:EBS) missed the analysts' consensus estimate of ($0.33) by $0.44 with a reported earnings per share (EPS) of ($0.77). Learn more on analysts' earnings estimate vs. EBS's actual earnings.

How can I listen to Emergent BioSolutions's earnings conference call?

The conference call for Emergent BioSolutions's latest earnings report can be listened to online. Listen to Conference Call

How can I read Emergent BioSolutions's conference call transcript?

The conference call transcript for Emergent BioSolutions's latest earnings report can be read online. Read Transcript

How can I view Emergent BioSolutions's earnings report?

Emergent BioSolutions's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Emergent BioSolutions generate each year?

Emergent BioSolutions (NYSE:EBS) has a recorded annual revenue of $1.05 billion.

How much profit does Emergent BioSolutions generate each year?

Emergent BioSolutions (NYSE:EBS) has a recorded net income of -$760.50 million. EBS has generated -$14.83 earnings per share over the last four quarters.

What is Emergent BioSolutions's EPS forecast for next year?

Emergent BioSolutions's earnings are expected to grow from ($13.98) per share to ($0.25) per share in the next year.


More Earnings Resources from MarketBeat

This page (NYSE:EBS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners